Tenders/CSC-Store (Drugs) IPR 126103196 - RFQ 22602322 / FMH - DMU

CSC-Store (Drugs) IPR 126103196 - RFQ 22602322 / FMH - DMU

Dubai Academic Health Corporation
Published: Sep 20, 2026
Updated: Sep 20, 2026
Source: dubai_esupply

About This Opportunity

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals. Located in United Arab Emirates, Middle East & North Africa, this opportunity is open to firms and consortiums.

Published through Dubai eSupply, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender, designated as "CSC-Store (Drugs) IPR 126103196 - RFQ 22602322 / FMH - DMU", is a Request for Quotation (RFQ) concerning the supply of pharmaceutical products for the "CSC-Store (Drugs)". The procurement is being managed in the United Arab Emirates through the Dubai eSupply platform, with "FMH - DMU" indicating the responsible healthcare entity. The tender focuses on acquiring specific drugs to maintain adequate stock levels in the central drug store. Typical requirements for such pharmaceutical procurements include adherence to rigorous quality standards, compliance with the regulations set forth by the UAE Ministry of Health and Prevention (MOHAP), and ensuring the drugs provided have sufficient shelf life and are sourced from reputable manufacturers. Bidders are expected to submit detailed quotations, presenting competitive pricing and outlining their delivery capabilities and quality assurance protocols. The RFQ process suggests that the contract award will be based on a thorough assessment of price, product quality, delivery reliability, and compliance with all tender stipulations. Companies must hold valid pharmaceutical trading and distribution licenses within the UAE to be eligible. The specific IPR and RFQ numbers are vital for accessing the complete tender documentation, which will detail the required drug list, quantities, and submission guidelines, via the Dubai eSupply portal.

Data provenance

This notice is sourced from Dubai eSupply and was originally published on September 20, 2026. Last refreshed today. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Dubai Academic Health Corporation

Dubai Academic Health Corporation has issued 1,382 procurement notices on BidsFactory, including 68 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Governance & Public Administration. All notices are published for United Arab Emirates. Notices are distributed via Dubai eSupply. Most recent publication: September 20, 2026.

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in United Arab Emirates. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Dubai eSupply to access the full notice, required documents, and submission instructions provided by the contracting authority.

Who is the contracting authority?

This notice was issued by Dubai Academic Health Corporation in United Arab Emirates. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

Find tenders like this automatically

Set up alerts and filters that match your business — never miss a relevant opportunity again.

See plans